Stability of Continuous Renal Replacement Therapy Solutions After Phosphate Addition: An Experimental Study

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 1, 2011, Pages 75-80

  Santiago, Maria José ^a   López Herce Cid, Jesús ^a   Muñoz, Rafael ^b   Del Castillo, Jimena ^a   Urbano, Javier ^a   Solana, Maria José ^a   Botrán, Marta ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b Pediatric Laboratory Department   (Spain)

Author keywords

Continuous renal replacement therapy; Dialysis fluid; Hypophosphatemia; Phosphate; Replacement fluid

Indexed keywords

CALCIUM ION; DIALYSIS FLUID; GLUCOSE; MAGNESIUM ION; PHOSPHATE;

ARTICLE; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICAL ILLNESS; EXPERIMENTAL STUDY; HYPOPHOSPHATEMIA; PH; PRECIPITATION; PRIORITY JOURNAL;

CALCIUM; CHEMICAL PRECIPITATION; DIALYSIS SOLUTIONS; MAGNESIUM; PHOSPHATES; PHOSPHORUS; RENAL REPLACEMENT THERAPY;

EID: 79251581291     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00877.x     Document Type: Article

References (16)

1. Troyanov S, Geadah D, Ghannoum M, Cardinal J, Leblanc M. Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Intensive Care Med 2004;30:1662-5.
2. Bugg NC, Jones JA. Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit. Anaesthesia 1998;53:895-902.
3. Charron T, Bernard F, Skrobik Y, Simoneau N, Gagnon N, Leblanc M. Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia. Intensive Care Med 2003;29:1273-8.
4. Khan MA, Yu AW, Cheng YL, Di Silvestro JA, Yung CY, Ing TS. Preparation of a phosphorus-enriched hemodialysate using an 'acid concentrate' solution and a sodium bicarbonate powder. Am J Nephrol 1998;18:172-3.
5. Sam R, Vaseemuddin M, Leong WH, Rogers BE, Kjellstrand CM, Ing TS. Composition and clinical use of hemodialysates. Hemodial Int 2006;10:15-28.
6. Dorval M, Pichette V, Cardinal J, Geadah D, Ouimet D, Leblanc M. The use of an ethanol- and phosphate-enriched dialysate to maintain stable serum ethanol levels during haemodialysis for methanol intoxication. Nephrol Dial Transplant 1999;14:1774-7.
7. Chow MT, Lin HJ, Mitra EA etal. Hemodialysis-induced hypophosphatemia in a normophosphatemic patient dialyzed for ethylene glycol poisoning: treatment with phosphorus-enriched hemodialysis. Artif Organs 1998;22:905-7.
8. Ing TS, Chebrolu SB, Cheng YL, Yu AW, Choi P, Kjellstrand CM. Phosphorus-enriched hemodialysates: formulations and clinical use. Hemodial Int 2003;7:148-55.
9. Santiago MJ, López-Herce J, Urbano J, Bellon JM, del Castillo J, Carrillo A. Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int 2009;75:312-6.
10. Morimatsu H, Uchino S, Bellomo R, Ronco C. Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations. Int J Artif Organs 2002;25:512-9.
11. Tan HK, Bellomo R, M'Pis DA, Ronco C. Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration. Int J Artif Organs 2001;24:186-91.
12. Allwood MC, Kearney MC. Compatibility and stability of additives in parenteral nutrition admixtures. Nutrition 1998;14:697-706.
13. Wong JC, McDougal AR, Tofan M, Aulakh J, Pineault M, Chessex P. Doubling calcium and phosphate concentrations in neonatal parenteral nutrition solutions using monobasic potassium phosphate. J Am Coll Nutr 2006;25:70-7.
14. Parikh MJ, Dumas G, Silvestri A, Bistrian BR, Driscoll DF. Physical compatibility of neonatal total parenteral nutrient admixtures containing organic calcium and inorganic phosphate salts. Am J Health Syst Pharm 2005;62:1177-83.
15. Newton DW, Driscoll DF. Calcium and phosphate compatibility: revisited again. Am J Health Syst Pharm 2008;65:73-80.
16. Hicks W, Hardy G. Phosphate supplementation for hypophosphataemia and parenteral nutrition. Curr Opin Clin Nutr Metab Care 2001;4:227-33.